← Back to Search

Treatment for Quality of Life

N/A
Waitlist Available
Led By Galen Switzer, Ph.D
Research Sponsored by Center for International Blood and Marrow Transplant Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Summary

To compare donors to their non-donor counterparts and healthy controls as well as to generate trajectory classes based on longitudinal patterns of donor HRQoL and identify predictors of poor donor HRQoL.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
HRQoL (Health Related Quality of Life)
Secondary study objectives
1 year post-donation
Donor characteristics

Find a Location

Who is running the clinical trial?

Center for International Blood and Marrow Transplant ResearchLead Sponsor
38 Previous Clinical Trials
200,192,676 Total Patients Enrolled
University of PittsburghOTHER
1,762 Previous Clinical Trials
16,347,249 Total Patients Enrolled
Galen Switzer, Ph.DPrincipal InvestigatorUniversity of Pittsburgh
~118 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top